178 related articles for article (PubMed ID: 35793869)
21. Immuno-oncology-microbiome axis of gastrointestinal malignancy.
Lin Q; Guan SW; Yu HB
World J Gastrointest Oncol; 2023 May; 15(5):757-775. PubMed ID: 37275452
[TBL] [Abstract][Full Text] [Related]
22. M1
Garrido-Martin EM; Mellows TWP; Clarke J; Ganesan AP; Wood O; Cazaly A; Seumois G; Chee SJ; Alzetani A; King EV; Hedrick CC; Thomas G; Friedmann PS; Ottensmeier CH; Vijayanand P; Sanchez-Elsner T
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32699181
[TBL] [Abstract][Full Text] [Related]
23. Genomic profiles and transcriptomic microenvironments in 2 patients with synchronous lung adenocarcinoma and lung squamous cell carcinoma: a case report.
Wu L; Kang P; Tao S; Zhao Z; Chen L; Xiao Y; Tan Q
BMC Med Genomics; 2020 Jan; 13(1):15. PubMed ID: 32005243
[TBL] [Abstract][Full Text] [Related]
24. The human tumor microbiome is composed of tumor type-specific intracellular bacteria.
Nejman D; Livyatan I; Fuks G; Gavert N; Zwang Y; Geller LT; Rotter-Maskowitz A; Weiser R; Mallel G; Gigi E; Meltser A; Douglas GM; Kamer I; Gopalakrishnan V; Dadosh T; Levin-Zaidman S; Avnet S; Atlan T; Cooper ZA; Arora R; Cogdill AP; Khan MAW; Ologun G; Bussi Y; Weinberger A; Lotan-Pompan M; Golani O; Perry G; Rokah M; Bahar-Shany K; Rozeman EA; Blank CU; Ronai A; Shaoul R; Amit A; Dorfman T; Kremer R; Cohen ZR; Harnof S; Siegal T; Yehuda-Shnaidman E; Gal-Yam EN; Shapira H; Baldini N; Langille MGI; Ben-Nun A; Kaufman B; Nissan A; Golan T; Dadiani M; Levanon K; Bar J; Yust-Katz S; Barshack I; Peeper DS; Raz DJ; Segal E; Wargo JA; Sandbank J; Shental N; Straussman R
Science; 2020 May; 368(6494):973-980. PubMed ID: 32467386
[TBL] [Abstract][Full Text] [Related]
25. Multi-Omics Analysis Elucidates The Immune And Intratumor Microbes Characteristics Of Ubiquitination Subtypes In Lung Adenocarcinoma.
Wang S; Liu P; Yu J; Liu T
Transl Oncol; 2023 Oct; 36():101754. PubMed ID: 37549605
[TBL] [Abstract][Full Text] [Related]
26. Transcriptomic architecture of the adjacent airway field cancerization in non-small cell lung cancer.
Kadara H; Fujimoto J; Yoo SY; Maki Y; Gower AC; Kabbout M; Garcia MM; Chow CW; Chu Z; Mendoza G; Shen L; Kalhor N; Hong WK; Moran C; Wang J; Spira A; Coombes KR; Wistuba II
J Natl Cancer Inst; 2014 Mar; 106(3):dju004. PubMed ID: 24563515
[TBL] [Abstract][Full Text] [Related]
27. Transcriptomic characterization and construction of M2 macrophage-related prognostic and immunotherapeutic signature in ovarian metastasis of gastric cancer.
Gao J; Zhao Z; Zhang H; Huang S; Xu M; Pan H
Cancer Immunol Immunother; 2023 May; 72(5):1121-1138. PubMed ID: 36336725
[TBL] [Abstract][Full Text] [Related]
28. The Intratumor Microbiota Signatures Associate With Subtype, Tumor Stage, and Survival Status of Esophageal Carcinoma.
Wang Y; Guo H; Gao X; Wang J
Front Oncol; 2021; 11():754788. PubMed ID: 34778069
[TBL] [Abstract][Full Text] [Related]
29. Nongenetic Evolution Drives Lung Adenocarcinoma Spatial Heterogeneity and Progression.
Tavernari D; Battistello E; Dheilly E; Petruzzella AS; Mina M; Sordet-Dessimoz J; Peters S; Krueger T; Gfeller D; Riggi N; Oricchio E; Letovanec I; Ciriello G
Cancer Discov; 2021 Jun; 11(6):1490-1507. PubMed ID: 33563664
[TBL] [Abstract][Full Text] [Related]
30. Identification and validation of core genes in tumor-educated platelets for human gastrointestinal tumor diagnosis using network-based transcriptomic analysis.
Jiang Y; He J; Wang X; Liu C; Zhou W; Liu D; Guo Z; Liu K
Platelets; 2023 Dec; 34(1):2212071. PubMed ID: 37212262
[TBL] [Abstract][Full Text] [Related]
31. The crosstalk of intratumor bacteria and the tumor.
Huang J; Mao Y; Wang L
Front Cell Infect Microbiol; 2023; 13():1273254. PubMed ID: 38235490
[TBL] [Abstract][Full Text] [Related]
32. A robust tool for discriminative analysis and feature selection in paired samples impacts the identification of the genes essential for reprogramming lung tissue to adenocarcinoma.
Toh SH; Prathipati P; Motakis E; Kwoh CK; Yenamandra SP; Kuznetsov VA
BMC Genomics; 2011 Nov; 12 Suppl 3(Suppl 3):S24. PubMed ID: 22369099
[TBL] [Abstract][Full Text] [Related]
33. [Correlation between Immune Microenvironment Features and EGFR Mutation Status
in Lung Adenocarcinoma].
Zhu H; Chen P; Dong G; Meng F; Xia Z; You J; Kong X; Wu J; Yuan F; Yu X; Sun Q; Ji J; Wang S; Liu T; Xu L
Zhongguo Fei Ai Za Zhi; 2023 Mar; 26(3):204-216. PubMed ID: 37035883
[TBL] [Abstract][Full Text] [Related]
34. The intratumor microbiome predicts prognosis across gender and subtypes in papillary thyroid carcinoma.
Gnanasekar A; Castaneda G; Iyangar A; Magesh S; Perez D; Chakladar J; Li WT; Bouvet M; Chang EY; Ongkeko WM
Comput Struct Biotechnol J; 2021; 19():1986-1997. PubMed ID: 33995898
[TBL] [Abstract][Full Text] [Related]
35. Tertiary Lymphoid Structure-B Cells Narrow Regulatory T Cells Impact in Lung Cancer Patients.
Germain C; Devi-Marulkar P; Knockaert S; Biton J; Kaplon H; Letaïef L; Goc J; Seguin-Givelet A; Gossot D; Girard N; Validire P; Lefèvre M; Damotte D; Alifano M; Lemoine FM; Steele KE; Teillaud JL; Hammond SA; Dieu-Nosjean MC
Front Immunol; 2021; 12():626776. PubMed ID: 33763071
[TBL] [Abstract][Full Text] [Related]
36. Role of the Immune Component of Tumor Microenvironment in the Efficiency of Cancer Treatment: Perspectives for the Personalized Therapy.
Stakheyeva M; Riabov V; Mitrofanova I; Litviakov N; Choynzonov E; Cherdyntseva N; Kzhyshkowska J
Curr Pharm Des; 2017; 23(32):4807-4826. PubMed ID: 28714406
[TBL] [Abstract][Full Text] [Related]
37. Construction of a Prognostic Immune Signature for Squamous-Cell Lung Cancer to Predict Survival.
Chen RL; Zhou JX; Cao Y; Sun LL; Su S; Deng XJ; Lin JT; Xiao ZW; Chen ZZ; Wang SY; Lin LZ
Front Immunol; 2020; 11():1933. PubMed ID: 33072067
[TBL] [Abstract][Full Text] [Related]
38. An aging-related signature predicts favorable outcome and immunogenicity in lung adenocarcinoma.
Zhang W; Li Y; Lyu J; Shi F; Kong Y; Sheng C; Wang S; Wang Q
Cancer Sci; 2022 Mar; 113(3):891-903. PubMed ID: 34967077
[TBL] [Abstract][Full Text] [Related]
39. Archaea Microbiome Dysregulated Genes and Pathways as Molecular Targets for Lung Adenocarcinoma and Squamous Cell Carcinoma.
Uzelac M; Li Y; Chakladar J; Li WT; Ongkeko WM
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232866
[TBL] [Abstract][Full Text] [Related]
40. Single-cell transcriptome analysis revealed a suppressive tumor immune microenvironment in EGFR mutant lung adenocarcinoma.
Yang L; He YT; Dong S; Wei XW; Chen ZH; Zhang B; Chen WD; Yang XR; Wang F; Shang XM; Zhong WZ; Wu YL; Zhou Q
J Immunother Cancer; 2022 Jan; 10(2):. PubMed ID: 35140113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
